GAITHERSBURG, Md., Nov. 22, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following conferences: Piper Sandler 33rd Annual Virtual Healthcare ConferenceNovember 29-December 2, 2021Webcast available now 5th Annual NASH Summit 2021November 30, 20219:00 am Eastern Time 4th Annual Evercore ISI HealthCONx ConferenceDecember 2, 202110:55 am Eastern Time Presentation materials, including webcast links to the Piper Sandler and Evercore ISI presentations, will be accessible on the Events section of the Altimmune website. About Altimmune Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com. Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter Altimmune Investor & Media Contact: Will BrownChief Financial OfficerPhone: 240-654-1450wbrown@altimmune.com